Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript
Acq. announced
Director departure
|
|
Adhera Therapeutics, Inc. (ATRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2018 |
8-K
| Resignation/termination of a director, Appointed a new director|
Docs:
|
"Omnibus Settlement Agreement, by and among Marina Biotech, Inc., Vuong Trieu, Ph.D., Autotelic Inc., Autotelic LLC, Autotelic BIO, Oncotelic, Inc. and LipoMedics, Inc",
"Marina Biotech Appoints Nancy R. Phelan to the Board of Directors Research Triangle Park, NC – October 3, 2018 – Marina Biotech, Inc. , a commercial stage pharmaceutical company focused on the development and commercialization of innovative therapeutics for hypertension, arthritis and pain, today announced that Nancy R. Phelan has been appointed to serve as a member of its Board of Directors, effective today." |
|
| 01/14/2009 |
8-K
| Resignation/termination of a director |
|
|